Stocksigma LogoStocksigma Logo

SMS Pharmaceuticals Q2 FY27 Results: PAT Surges 57% YoY to ₹39.85 Crore

SMS Pharmaceuticals reported a consolidated revenue from operations of ₹316.09 crore for Q2 ended 30th Sep'26, rising 30.38% YoY from ₹242.43 crore and

SMS Pharmaceuticals Q2 FY27 Results: PAT Surges 57% YoY to ₹39.85 Crore

SMS Pharmaceuticals Ltd · Others (Uncategorized) · 04 Nov 2026, 7:09 pm

SMS Pharmaceuticals Q2 FY27 Results: PAT Surges 57% YoY to ₹39.85 Crore SMS Pharmaceuticals reported a consolidated revenue from operations of ₹316.09 crore for Q2 ended 30th Sep'26, rising 30.38% YoY from ₹242.43 crore and 52.73% QoQ. Consolidated net profit grew 57.44% YoY to ₹39.85 crore compared to ₹25.31 crore in Q2 ended 30th Sep'25, with basic EPS increasing to ₹4.26 from ₹2.84 YoY. Additionally, the board approved the resignation of Company Secretary Thirumalesh Tumma effective 4th Nov'26 and appointed Manohar Mollama as the new Company Secretary & Compliance Officer effective 5th Nov'26.

Original exchange filing (PDF)

More announcements from SMS Pharmaceuticals Ltd

All SMS Pharmaceuticals Ltd announcements